Anti-MuSK antibodies: correlation with myasthenia gravis severity.
about
Thymomas: review of current clinical practice.Characterization of B cells in muscle-specific kinase antibody myasthenia gravis.Non-neuronal cholinergic activity is potentiated in myasthenia gravis.Muscle autoantibodies in myasthenia gravis: beyond diagnosis?Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.Myasthenia gravis: a clinical-immunological update.Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.Stable expression of human muscle-specific kinase in HEp-2 M4 cells for automatic immunofluorescence diagnostics of myasthenia gravis.The auto-antigen repertoire in myasthenia gravis.Diagnostic use of autoantibodies in myasthenia gravis.Myasthenia gravis: recent advances in immunopathology and therapy.Rituximab treatment of myasthenia gravis: A systematic review.Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis.Prognostic factors and health-related quality of life in ocular Myasthenia Gravis (OMG).Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis.Clinical and experimental features of MuSK antibody positive MG in Japan.Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.Double Seropositive Myasthenia Gravis: A 5-Year Follow-Up.Treatment of MuSK-Associated Myasthenia Gravis.Management challenges in muscle-specific tyrosine kinase myasthenia gravis.Role of the clinical immunology laboratory in disease monitoring
P2860
Q34094814-F484AB65-3D1D-424F-AFBC-1190DC6F5133Q35134860-4E5BAADE-0D81-4E55-AAF8-38A041CE9BF4Q36274478-46B16675-D160-46E5-AE76-A20528AE0D85Q36420763-8D8EBDD6-76E2-4848-84F3-4D5A21AB2434Q36484383-CCF336BF-700E-42E8-B52B-E0CBBCC0BAFDQ36783864-BC3FA97D-E7D5-4954-8E3D-4E8947A0BB05Q37252133-A6A58C1F-D09E-4BD7-8977-4DCDBC7D87C9Q37288598-56A4B319-2AD3-4493-8F58-0543F5448167Q37458471-B52EEED9-FB60-4E88-AFBB-503431FDE9DDQ37727984-AEF9BBF8-185F-40D9-89A0-3AAC2B32A927Q37727987-539A97ED-515B-4101-8886-519CD32C3902Q38969032-51A818FA-7D9E-4C94-A3AF-BE90953EEFBAQ39121466-3A1783D9-ADA2-46E4-BFC0-A91AD5540CB4Q41846224-C9282AE0-EDF3-4078-A6D8-20DB90574840Q48135299-B2EAA42A-452A-41B9-895D-D26AFF22C571Q48142572-17E5BAE9-1D72-465C-94FA-D844EE888419Q51740649-ED1D220C-884D-4064-8904-39891F78928AQ53080071-8E40BED8-6F82-4F6D-9D73-4167A68DE233Q54116089-015CAD1C-0251-4A40-92FC-2E88ED06FB8FQ54192842-CF7AA60A-F29B-4104-AF70-9604C7B05191Q54379059-04120226-FB08-4546-9413-5E445922F3B0Q54464610-7CD2D433-AB17-4D1A-A006-B0A9CDA7DE60Q59102177-34E3361E-642D-4C5F-9F6C-67DBA1F5AA2E
P2860
Anti-MuSK antibodies: correlation with myasthenia gravis severity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Anti-MuSK antibodies: correlation with myasthenia gravis severity.
@en
Anti-MuSK antibodies: correlation with myasthenia gravis severity.
@nl
type
label
Anti-MuSK antibodies: correlation with myasthenia gravis severity.
@en
Anti-MuSK antibodies: correlation with myasthenia gravis severity.
@nl
prefLabel
Anti-MuSK antibodies: correlation with myasthenia gravis severity.
@en
Anti-MuSK antibodies: correlation with myasthenia gravis severity.
@nl
P2093
P1433
P1476
Anti-MuSK antibodies: correlation with myasthenia gravis severity.
@en
P2093
P304
P356
10.1212/01.WNL.0000228225.23349.5D
P407
P577
2006-08-01T00:00:00Z